Ingrezza 80 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FX4D8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,245
Award facts
- Contract value 100% obligated
- $4,244.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $4,244.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Ingrezza 80 mg capsules (30-count units). This is a non-set-aside competitive award with a completion date of January 30, 2026. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical vendor in the federal pharmaceutical supply chain and holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026.
This delivery order represents a task order under AmerisourceBergen's existing IDC with the Defense Logistics Agency, which enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Ingrezza is a prescription medication used in the treatment of movement disorders, reflecting the company's role in delivering specialized neurological and psychiatric medications to federal medical institutions, including military treatment facilities and veterans' healthcare systems. The delivery order structure and firm fixed-price model are consistent with DLA's standard procurement approach for managing pharmaceutical inventory through its qualified prime vendors.
Quick answers
Who was awarded contract SPE2DR26FX4D8?
SPE2DR26FX4D8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FX4D8 worth?
The government has obligated $4,245 on SPE2DR26FX4D8.
Is contract SPE2DR26FX4D8 an order under another contract?
Yes. SPE2DR26FX4D8 is a delivery order under SPE2DR25D2218, an indefinite delivery contract.
Was contract SPE2DR26FX4D8 competed?
The extent of competition for SPE2DR26FX4D8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award